Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S.

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

To add insult to injury, many hospitals that aggressively pursue unpaid medical bills profit from a federal drug discount program: the 340B Drug Pricing Program, which was established to help ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...

NuvemRx, a leading tech-enabled pharmacy solutions company for community health providers, today announced it has acquired ...

Mere days before the Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program’s (“Pilot”) scheduled January 1, 2026 effective date, a federal district court granted a ...

Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...

Medicare’s Maximum Fair Price (MFP) officially went live on January 1st. Select Medicare Part D drugs are now subject to negotiated pricing under the Inflation Reduction Act, with 15 additional Part D ...

A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...

WATKINSVILLE, GA / ACCESS Newswire / January 29, 2026 / In an era where staffing shortages, cost containment, and regulatory complexity challenge healthcare operations, pharmacy support offers ...

Sagebrush Health Services, a nonprofit organization serving over 10,000 Nevada patients, has filed a lawsuit against Amgen Inc. (NASDAQ: AMGN), alleging that Amgen acted unlawfully by unilaterally ...